Mentis Cura AS is an innovative company developing biomarkers based on electroencephalography (EEG). Mentis Cura’s technology is positioned to dramatically improve access to affordable brain diagnostics. For individuals with dementia, early and accurate diagnosis ensures they get the most appropriate care as soon as possible and helps them and their families understand the disease better before it progresses. From a health care system perspective, early and accurate diagnosis promotes better use of limited resources and accelerates and reduces cost of clinical trials for new drugs.
The products are developed using Statistical Pattern Recognition – a proprietary combination of cutting edge machine learning methods coupled with over a decade of practice EEG biomarker experience.